George A Doherty

age ~56

from Libertyville, IL

Get Report

Also known as:

George Andrew Doherty
George A Doheny

Connected to:

George Doherty Phones & Addresses

Libertyville, IL
Superior, CO
Crown Point, IN
Waukegan, IL
Colorado Springs, CO
Princeton, NJ
Auburn, NY
Perris, CA
Superior, CO
Stanford, CA
Boulder, CO

Work

Company:

The George Doherty Team | Berkshire Hathaway
Address:

Denver, CO
Phones:

(702)2452441

Skills

Contract Negotiating • Luxury Home Sales • Luxury Condominum • Luxury Townhomes • Downtown Denver Real Estate

Languages

English

Ranks

Licence:

New Jersey - Active
Date:

1978

Interests

Weight Lifting • Running • Hiking • Camping • Cars • Travel • Real Estate

Images

Specialities

REO / Bank Owned • Short sales • Residential sales • Luxury homes • First time home buyers • Distressed properties • Probate • Relocation

Isbn (Books And Publications)

Proceedings of the 5th Rocky Mountain Region Disaster Mental Health Conference

view source

Author
George W. Doherty

ISBN #
1932690379

Lawyers & Attorneys

George M Doherty - Lawyer

view source

Licenses:

New Jersey - Active 1978

Name / Title

Company / Classification

Phones & Addresses

George Doherty
Operations Manager

Rand Worldwide Subsidiary, Inc
Computer Aided Design and Computer Aided Mfg

3601 Algonquin Rd, Rolling Meadows, IL 60008

Us Patents

Substituted N-Arylsulfonyl-Proline Derivatives As Potent Cell Adhesion Inhibitors
view source
US Patent:

6943180, Sep 13, 2005
Filed:

Mar 15, 2002
Appl. No.:

10/472303
Inventors:

George Doherty - Superior CO, US
Linus S Lin - Westfield NJ, US
William K. Hagmann - Westfield NJ, US
Ginger Xu-qiang Yang - Jersey City NJ, US
Linda L. Chang - Wayne NJ, US
Shrenik K. Shah - Metuchen NJ, US
Richard A. Mumford - Red Bank NJ, US
Theodore Kamenecka - San Diego CA, US
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

C07D215/20
A61K031/47
US Classification:

514335, 514332, 514333, 546255, 546256, 546262
Abstract:

Compounds of formula (I) are antagonists of VLA-4 and/or alpha4/beta7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of AIDS-related dementia, allergic conjunctivitis, allergic rhinitis, Alzheimer's disease, asthma, atherosclerosis, autologous bone marrow transplantation, certain types of toxic and immune-based nephritis, contact dermal hypersensitivity, inflammatory bowel disease including ulcerative colitis and Crohn's disease, inflammatory lung diseases, inflammatory sequelae of viral infections, meningitis, multiple sclerosis, multiple myeloma, myocarditis, organ transplantation, psoriasis, pulmonary fibrosis, restenosis, rhinitis, rheumatoid arthritis, septic arthritis, stroke, tumor metastasis, uveititis, and type I diabetes.

1-(Amino)Indanes And (1,2-Dihydro-3-Amino)-Benzofurans, Benzothiophenes And Indoles As Edg Receptor Agonists
view source
US Patent:

7220734, May 22, 2007
Filed:

Dec 16, 2003
Appl. No.:

10/536730
Inventors:

George A. Doherty - Superior CO, US
Jeffrey J. Hale - Westfield NJ, US
Sander G. Mills - Scotch Plains NJ, US
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 31/397
A61K 31/4245
A61K 31/41
A61K 31/4025
A61K 31/381
C07D 271/06
C07D 257/04
C07D 405/12
C07D 409/12
US Classification:

51421017, 514364, 514381, 514422, 514444, 548131, 548251, 548517, 549 59
Abstract:

The present invention encompasses compounds of Formula (I): as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.

N-(Benzyl)Aminoalkylcarboxylates, Phosphinates, Phosphonates And Tetrazoles As Edg Receptor Agonists
view source
US Patent:

7351725, Apr 1, 2008
Filed:

Jan 14, 2003
Appl. No.:

10/500811
Inventors:

George A. Doherty - Superior CO, US
Zhen Li - Scotch Plains NJ, US
Jeffrey J. Hale - Westfield NJ, US
Sander G. Mills - Scotch Plains NJ, US
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

A61K 31/4245
A61K 31/38
C07D 333/22
C07D 413/04
US Classification:

514364, 514438, 548131, 549 77
Abstract:

The present invention encompasses compounds of Formula (I) as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.

8-Substituted Benzoazepines As Toll-Like Receptor Modulators
view source
US Patent:

8153622, Apr 10, 2012
Filed:

Aug 17, 2006
Appl. No.:

12/064193
Inventors:

George A. Doherty - Superior CO, US
C. Todd Eary - Longmont CO, US
Robert D. Groneberg - Boulder CO, US
Zachary Jones - Broomfield CO, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

A61P 37/00
A61K 31/55
C07D 223/16
C07D 403/10
US Classification:

51421202, 51421301, 540543, 540593
Abstract:

Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in the treatment of autoimmunity, inflammation allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency.

Aminodiazepines As Toll-Like Receptor Modulators
view source
US Patent:

8163738, Apr 24, 2012
Filed:

Aug 17, 2006
Appl. No.:

12/064196
Inventors:

George A. Doherty - Superior CO, US
Zachary Jones - Broomfield CO, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

A61P 37/02
A61K 31/5513
C07D 243/20
US Classification:

514221, 540510, 540543, 540571
Abstract:

Provided are compositions and methods useful for modulation signaling through the Toll-like receptor TLR8. The compositions and methods have use in the treatment of autoimmunity, inflammation allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency.

4-Substituted Phenoxyphenylacetic Acid Derivatives
view source
US Patent:

8183289, May 22, 2012
Filed:

Aug 21, 2007
Appl. No.:

12/438112
Inventors:

George Doherty - Libertyville IL, US
Adam Cook - Broomfield CO, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

C07D 211/22
C07D 211/84
C07D 333/22
C07D 233/00
C07C 229/00
A01N 37/12
A01N 37/44
US Classification:

514563, 546316, 5483235, 549 77, 562455
Abstract:

Compounds of Formula (I): in which R, R, R, R, R, Rand A have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

8-Substituted Benzoazepines As Toll-Like Receptor Modulators
view source
US Patent:

8304407, Nov 6, 2012
Filed:

Mar 7, 2012
Appl. No.:

13/414579
Inventors:

George A. Doherty - Libertyville IL, US
Charles Todd Eary - Longmont CO, US
Robert D. Groneberg - Boulder CO, US
Zachary Jones - Broomfield CO, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

A61P 37/00
A61K 31/55
C07D 223/16
C07D 403/10
US Classification:

51421202, 51421301, 540543, 540593
Abstract:

Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in the treatment of autoimmunity, inflammation allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency.

4-Heteroaryl-Substituted Phenoxyphenylacetic Acid Derivatives
view source
US Patent:

8362056, Jan 29, 2013
Filed:

Nov 4, 2008
Appl. No.:

12/739560
Inventors:

George A. Doherty - Libertyville IL, US
Assignee:

Array BioPharma Inc. - Boulder CO
International Classification:

A01N 43/52
A01N 43/56
A01N 43/38
A61K 31/415
A61K 31/405
C07D 235/00
C07D 231/56
C07D 209/04
US Classification:

514394, 514403, 514415, 5483044, 5483611, 548469
Abstract:

Compounds of Formula I: I in which D, D, R, R, R, Rand A have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

Real Estate Brokers

George Doherty, Denver CO Broker

view source

Specialties:

REO / Bank Owned
Short sales
Residential sales
Luxury homes
First time home buyers
Distressed properties
Probate
Relocation

Work:

The George Doherty Team | Berkshire Hathaway
Denver, CO
(702)2452441 (Phone)
License #FA#100048680

Client type:

Home Buyers
Home Sellers

Property type:

Single Family Home
Condo/Townhome
Multi-family

Interests:

Weight Lifting
Running
Hiking
Camping
Cars
Travel
Real Estate

Languages:

English

Skills:

Contract Negotiating
Luxury Home Sales
Luxury Condominum
Luxury Townhomes
Downtown Denver Real Estate

About:

Biography of George Doherty As a trusted and reliable real estate Broker Associate, George Doherty has a proven background in providing quality service while exceeding expectations with outstanding results. He is serious about helping people and goes out of his way to assist his clients in locating, selling or investing in real estate. George also has a background of many years in the loan and mortgage industry, so he is able to prepare all necessary paperwork effectively so that it moves through the proper channels in an expedited manner. Staying up to date with all the latest economic facts and local market data, he advises and aids his clients in all facets of their real estate transactions. Clarkston Michigan | From the Midwest Born and raised in the Midwest, George graduated from Clarkston High School in Michigan and later began his career handling loans and mortgages for customers of Direct Equity Mortgage, Custom Home Loans, Mountain View Mortgage, and Indy Mac Bank. This included originating loans and helping bankruptcy and/or foreclosure clients to achieve home ownership and improve their credit. George utilized mortgage knowledge expertise to effectively process and secure approvals for a high volume of difficult mortgages, successfully helping many clients get their first home. Colorado Broncos Colorado Licensed Licensed for real estate sales in the state of Colorado, George pursues continuing education in all aspects of real estate. This includes numerous seminars, workshops and personalized training from some of the greatest experts in the field. His objective is to stay knowledgeable and up to date so that he can continue to provide the best service he can to his real estate customers. Recognized in the News Recognized as a friendly expert in real estate and the mortgage industry, George has been a featured on Fox 5 News and News 3 Las Vegas, as well as In Business Las Vegas. He also has articles published in Nevada Woman Magazine, Henderson Daily News, and other publications. In addition, George has also functioned as a speaker for various seminars and workshops on various subjects, including marketing and marketing analysis. Taking A Personal Approach George takes a personal interest in monitoring and analyzing the Denver and Metro Denver real estate market and paying close attention to economic activity in the United States. Though George's life may seem consumed with real estate, he also enjoys working out and is an active troop leader for the Boy Scouts of America, encouraging his son in learning good values. He loves a challenge and pushes himself to high levels of achievement in everything he does. This can be seen in his MMA Fighterachievement of ranking second place in the U.S. Nationals of Grappling as a Mixed Martial Arts fighter. He doesn't just push himself in his personal life, but also uses his individual drive to help his clients get the best results. Committed with Good Values George now lives in Castle Pines, Colorado with his sweetheart of 21 years and they have two wonderful children together. Knowing the value and importance of a family, he really enjoys helping others purchase or sell their home so they can achieve the necessary goals for the betterment of their own personal life with their families.

Resumes

Medicinal Chemist

view source

Location:

Chicago, IL

Industry:

Pharmaceuticals

Work:

Abbvie
Medicinal Chemist
Abbott Jan 2008 - Dec 2012
Medicinal Chemist
Array Biopharma Inc. 1999 - 2002
Scientist
Merck 1998 - 2002
Research Scientist

Education:

Stanford University 1992 - 1999
Doctorates, Doctor of Philosophy, Philosophy, Organic Chemistry Purdue University 1992 - 1997
Bachelors, Bachelor of Science, Pharmacy

Skills:

Research
Oncology